| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Adrenomedullin (HuBit Genomix) | Phase 2 Clinical | National Cerebral And Cardiovascular Center, Hubit Genomix | CADASIL | Details | |
| Adrenomedullin (University of Miyazaki) | PEG5000-h.AM (1-52) | Phase 2 Clinical | University Of Miyazaki | Colitis, Ulcerative | Details |
| GUB-014295 | GUB-014295; GUB014295 | Phase 1 Clinical | Gubra A/S, Quotient Sciences Ltd | Overweight | Details |
| Pegylated Human Adrenomedullin | HM-201; HM-101; HM101 | Phase 1 Clinical | Himuka AM Pharma Corp | Colitis, Ulcerative; Crohn Disease | Details |